Podcast Disclaimer


By accessing this Podcast, you acknowledge that the entire contents and design of this Podcast, are the property of the podcast channel the Rebellious Investor (“Podcast Channel”).  Users of this Podcast may save and use information contained in the Podcast only for personal or other non-commercial, educational purposes. No other use, including, without limitation, reproduction, re-transmission or editing, of this Podcast may be made without the prior written permission of this Podcast Channel, which may be requested by sending an email to #insert email address#.



The primary purpose of this Podcast Channel is to educate and inspire others.  By accessing this Podcast, you acknowledge that the information, opinions, and recommendations presented in this Podcast are for general information only and do not constitute financial, economic, legal, accounting, or tax advice or recommendations.  You acknowledge that any reliance on the information provided in this Podcast is done at your own risk and does not take into account your individual objectives, financial situation or needs. Unless specifically stated otherwise, the Podcast Channel does not endorse, approve or recommend any information, product, service, or organisation presented or mentioned in this Podcast. The views and opinions expressed in this Podcast Channel are not necessarily those of any organisation or company that a host or guest works for. 


We cannot guarantee the accuracy of the information in this Podcast, including any financial, taxation, and/or legal information. Past performance is not a reliable indicator of future performance. All price references and market forecasts are as of the date of recording.


This Podcast Channel does not make any representation or warranty, express or implied, as to the accuracy, completeness or sufficiency of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed.


20 September 2021